Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124901722 | 12490172 | 2 | F | 2015 | 20160815 | 20160622 | 20160817 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-38477BP | BOEHRINGER INGELHEIM | 0.00 | F | Y | 0.00000 | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124901722 | 12490172 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 21395 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | ||||||
| 124901722 | 12490172 | 2 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | STRENGTH: 250 MCG / 50 MCG; FORMULATION: INHALATION AEROSOL | 0 | BID | |||||||||
| 124901722 | 12490172 | 3 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 1 ANZ | 0 | TABLET | QD | ||||||||
| 124901722 | 12490172 | 4 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 124901722 | 12490172 | 5 | C | BENTYL | DICYCLOMINE HYDROCHLORIDE | 1 | Oral | 60 MG | 0 | 20 | MG | CAPSULE | TID | ||||||
| 124901722 | 12490172 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 175 MCG | 0 | 175 | UG | TABLET | QD | ||||||
| 124901722 | 12490172 | 7 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 8 MG | 0 | 4 | MG | TABLET | BID | ||||||
| 124901722 | 12490172 | 8 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | ||||||
| 124901722 | 12490172 | 9 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 600 MG | 0 | 300 | MG | CAPSULE | BID | ||||||
| 124901722 | 12490172 | 10 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | FORMULATION: INHALATION SOLUTION | 0 | ||||||||||
| 124901722 | 12490172 | 11 | C | BUMEX | BUMETANIDE | 1 | Oral | 2 MG | 0 | 1 | MG | TABLET | BID | ||||||
| 124901722 | 12490172 | 12 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | Oral | 60 MEQ | 0 | 20 | MEQ | TABLET | TID | ||||||
| 124901722 | 12490172 | 13 | C | XANAX | ALPRAZOLAM | 1 | Oral | 1.5 MG | 0 | .5 | MG | TABLET | TID | ||||||
| 124901722 | 12490172 | 14 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 124901722 | 12490172 | 15 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 100 MG | 0 | 50 | MG | BID | |||||||
| 124901722 | 12490172 | 16 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | STRENGTH: SLIDING SCALE; | 0 | TID | |||||||||
| 124901722 | 12490172 | 17 | C | ANTIVERT | MECLIZINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124901722 | 12490172 | 1 | Chronic obstructive pulmonary disease |
| 124901722 | 12490172 | 2 | Chronic obstructive pulmonary disease |
| 124901722 | 12490172 | 3 | Product used for unknown indication |
| 124901722 | 12490172 | 4 | Panic attack |
| 124901722 | 12490172 | 5 | Product used for unknown indication |
| 124901722 | 12490172 | 6 | Hypothyroidism |
| 124901722 | 12490172 | 7 | Diabetes mellitus |
| 124901722 | 12490172 | 8 | Diabetes mellitus |
| 124901722 | 12490172 | 9 | Neuralgia |
| 124901722 | 12490172 | 10 | Chronic obstructive pulmonary disease |
| 124901722 | 12490172 | 11 | Product used for unknown indication |
| 124901722 | 12490172 | 12 | Product used for unknown indication |
| 124901722 | 12490172 | 13 | Anxiety |
| 124901722 | 12490172 | 14 | Post-traumatic stress disorder |
| 124901722 | 12490172 | 15 | Diabetes mellitus |
| 124901722 | 12490172 | 16 | Diabetes mellitus |
| 124901722 | 12490172 | 17 | Dizziness |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124901722 | 12490172 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124901722 | 12490172 | Asthenia | |
| 124901722 | 12490172 | Blood iron decreased | |
| 124901722 | 12490172 | Dyspnoea | |
| 124901722 | 12490172 | Gastrointestinal polyp haemorrhage | |
| 124901722 | 12490172 | Ovarian disorder | |
| 124901722 | 12490172 | Pericardial effusion | |
| 124901722 | 12490172 | Pneumonia | |
| 124901722 | 12490172 | Sepsis | |
| 124901722 | 12490172 | Small intestine polyp |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124901722 | 12490172 | 1 | 2011 | 0 | ||
| 124901722 | 12490172 | 7 | 2010 | 0 |